MedDataX Logo

Effect of Strength and Conditioning Training on Functional Performance in Children With Chronic Kidney Disease

NCT ID: NCT05657236

Last Updated: 2022-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-01

Study Completion Date

2024-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite the benefits of physical rehabilitation among adults and children with chronic illness, they avoid to engage in different physical activities especially pediatric population. Most of the children with Chronic kidney disease receive their medical treatment and follow-up with no change of their functional performance. We still lack the evidence of plyometric exercises in pediatric population with Chronic kidney disease . Therefore, the primary aim of this study is to explore the effects of strength and conditioning training in the form of plyometric exercises on balance and muscle strength in children with Chronic kidney disease .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Diseases

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Chronic Kidney Diseases plyometric exercises muscle strength balance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

Group Type OTHER

medical treatment

Intervention Type OTHER

traditional medical treatment and regular follow-up

Experimental group

Group Type EXPERIMENTAL

medical treatment

Intervention Type OTHER

traditional medical treatment and regular follow-up

plyometric exercise

Intervention Type OTHER

Each session starts with a 5-minute warm-up of flexibility exercises (active range motion and stretching exercises).The main plyometric exercise set will be applied for 20-30 minutes and consisted of 10 exercises directed at the lower body that gradually progress by increasing the set/repetition number in two exercise blocks, each continue for 1 month .The cool down period is 5 minutes and includes walking at self-preferred speed and static stretches of the major muscle groups.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

medical treatment

traditional medical treatment and regular follow-up

Intervention Type OTHER

plyometric exercise

Each session starts with a 5-minute warm-up of flexibility exercises (active range motion and stretching exercises).The main plyometric exercise set will be applied for 20-30 minutes and consisted of 10 exercises directed at the lower body that gradually progress by increasing the set/repetition number in two exercise blocks, each continue for 1 month .The cool down period is 5 minutes and includes walking at self-preferred speed and static stretches of the major muscle groups.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age will be ranged from 6-10 years.
* Both genders were included.
* Can follow instructions.
* Medically stable sedentary children with CKD, GFR (stage 2 (mild) eGFR of 60-89 ml/min per 1.73 m2, stage 3 (moderate) eGFR 30-59 ml/min per 1.73 m2) stage 4 (severe) eGFR of 15-29 ml/min per 1.73 m2.
* Did not yet require renal replacement therapy (non-dialysis).

Exclusion Criteria

* Recent myocardial infarction, uncontrolled hypertension, unstable angina, symptomatic left ventricular fibrillation.
* Severe uncontrolled diabetes,
* Neurological or cognitive disorders
* Peripheral vascular disease.
Minimum Eligible Age

6 Years

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amira Mahmoud Abd-elmonem

Assist Prof. Physiacl therapy for pediatric department, faculty of physical therapy , Cairo university

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amira M Mahmoud

Role: PRINCIPAL_INVESTIGATOR

Cairo university, faculty of physical therapy

Amira M Al-tohamy

Role: STUDY_CHAIR

Cairo university, faculty of physical therapy

Rasha M Helmy

Role: STUDY_DIRECTOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amira Mahmoud Abd-elmonem

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amira M Abd-elmonem

Role: CONTACT

Phone: 01155553316

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Amira M Abd-elmonem

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

chronic kidney disease

Identifier Type: -

Identifier Source: org_study_id